Trimetazidine Dihydrochloride

DRUG2 trials

Sponsors

The University of Queensland, Ain Shams University

Conditions

Amyotrophic Lateral SclerosisDiabetes Mellitus, Type 2Diabetic CardiomyopathiesMotor Neuron Disease

Phase 2

Targeting Metabolic Flexibility in Amyotrophic Lateral Sclerosis (ALS)

CompletedNCT04788745

The University of QueenslandAmyotrophic Lateral Sclerosis, Motor Neuron Disease

Start: 2021-06-29End: 2023-05-24Updated: 2023-07-20

Efficacy of Trimetazidine in Diabetic Patients

Ain Shams UniversityDiabetes Mellitus, Type 2, Diabetic Cardiomyopathies

Start: 2022-09-18End: 2023-09-30Target: 60Updated: 2022-09-27

Related Papers

An open-label Phase 2a study to assess the safety and tolerability of trimetazidine in patients with amyotrophic lateral sclerosis

Brain Communications2024-12-241 citations